Grifols ( Grifols )

Grifols

Grifols's picture

About Grifols

Grifols is a global healthcare company whose mission is to improve the health and well being of people around the world. We accomplish this mission by producing life-saving protein therapies for patients and by providing hospitals, pharmacies and healthcare professionals with the tools they need to deliver expert medical care.

Grifols press release, blog etc

08/16/2018 - 07:09 Grifols Announces Winner of the 2018 SPIN Award for Immunoglobulin Research in Neurology at the 2018 Peripheral Nerve Society Annual Meeting
08/14/2018 - 06:50 Procleix Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix Panther System
08/02/2018 - 22:37 Grifols achieves key milestone with FDA approval of the new Consolidated Manufacturing Facility (CMF) for production of recombinant proteins
08/01/2018 - 05:34 Grifols expands its plasma collection network by acquiring 24 Biotest centers in the United States
07/27/2018 - 11:18 Grifols increases net profits by 15% to EUR 319 million, with sustained operational revenue growth of 7%
07/16/2018 - 14:04 Grifols has been included in the FTSE4Good Index
07/05/2018 - 11:01 Grifols, the newest angel of elBullifoundation
06/28/2018 - 15:19 Grifols discloses transfers of value made to European healthcare professionals and health-sector organizations in 2017
06/19/2018 - 14:57 Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
06/04/2018 - 08:05 Grifols and IrsiCaixa join forces to promote biomedical research on HIV and associated diseases
06/03/2018 - 09:39 Grifols Announces New Agreement with Henry Schein to Distribute Normal Saline Solution in the U.S.
05/31/2018 - 09:41 Grifols Strengthens Environmental Commitment with First National Certification in Johnston County
05/31/2018 - 09:01 Grifols Launches a New Testing Service for Patients Treated with Daratumumab
05/25/2018 - 09:52 Grifols culminates a year of growth and approves the distribution of a record EUR 265 million in dividends
05/23/2018 - 09:31 Grifols publishes its 2017 Corporate Responsibility Report as part of its commitment to transparency
05/14/2018 - 09:07 Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents
05/10/2018 - 09:00 Grifols reaches an agreement with Boya Bio-Pharmaceutical to open plasma collection centers in China
05/03/2018 - 08:21 Grifols increases its net profit by 7% to Euros 143 million and delivers significant growth in organic sales